Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

It is narked not only by motor symptoms – such as tremors, stiffness, and bradykinesia – but also by cognitive decline. PD is also characterized by the degeneration and death of nerve cells in the ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people ...